BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
– BRTX-100 is the first and only stem cell product candidate cleared…
Kia EV3 Wins Compact SUV Category at the 2025 Womens Worldwide Car of the Year Awards
EV3 hailed for automotive innovation, performance, and value for moneySix category winners…
PureTechs Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial
Dose-ranging trial evaluated deupirfenidone 550 mg three times a day (TID) (approximately…
Globally top 5%, Astronergy won greater-value EcoVadis group scope gold rating
HANGZHOU, China, Dec. 9, 2024 /PRNewswire/ -- Astronergy, full name in Chint…
